Uscom Limited announced an extension of its ongoing partnership with digital biomarker leader Koneksa to develop and use Uscom's digital patient-monitoring technology for spirometers in clinical trials. The agreement between the companies relates to the direct wireless integration of data from the Uscom's SpiroSonic AIR device into Koneksa's proprietary platform.